Presentation TCT 2013 Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) Presenter: Stephan Windecker October 29, 2013
Presentation TCT 2013 When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist Presenter: Ulrich Jorde October 29, 2013
Presentation TCT 2013 Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry Presenter: Loes Hoebers October 29, 2013
Presentation TCT 2013 Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal Presenter: Michael Argenziano October 29, 2013
Presentation TCT 2013 TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona... Presenter: Yelin Zhao October 29, 2013
Presentation TCT 2013 PCI vs CABG: A Transparent Analysis of the Current Randomized Trial Data for Different Types of Patients Presenter: Ajay Kirtane October 29, 2013
Presentation TCT 2013 The Decision to Revascularize Must Be Made on the Background of Improving Medical Therapies and Life Style Modification, with Greater Longevity Presenter: David Maron October 29, 2013
Presentation TCT 2013 TCT-47. Angiographic And Procedural Outcome Of Percutaneous Coronary Intervention With The STENTYS® Self-Apposing Coronary Stent In Patients Not Treated For STEMI. Presenter: Huangling Lu October 29, 2013